Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug

Keyphrases

• Antiangiogenic Agents 100%
• Autoimmune 100%
• Methionine Aminopeptidase (MetAP) 100%
• Retinal Inflammation 100%
• Inflammatory Cytokines 66%
• T Helper 17 (Th17) 66%
• CD4+ T Cells 66%
• T Cells 33%
• Inflammation 33%
• Mouse Model 33%
• Receptor-mediated 33%
• Immune Response 33%
• Retina 33%
• T Helper Cells 33%
• T Cell Differentiation 33%
• T Cell Proliferation 33%
• Cellular Proteins 33%
• Protein Synthesis 33%
• T Cell Activation 33%
• Lymph Node 33%
• T Cell Receptor 33%
• Legal Blindness 33%
• Chronic Uveitis 33%
• Western World 33%
• Systemic Immune Response 33%
• Th1-Th2 33%
• Experimental Autoimmune Uveitis 33%
• Th1 Cells 33%
• Recurrent Uveitis 33%
• Autoimmune Uveitis 33%

Immunology and Microbiology

• Aminopeptidase 100%
• Proinflammatory Cytokine 100%
• T-Helper Cell 100%
• Angiogenesis Inhibitor 100%
• Autoimmune Uveitis 100%
• T Cell 50%
• Protein Synthesis 50%
• Mouse Model 50%
• Cell Differentiation 50%
• Downregulation 50%
• T Cell Proliferation 50%
• Th17 Cell 50%
• T Cell Receptor 50%
• T Cell Activation 50%
• Lymph Node 50%
• Immunity 50%
• T Helper Cell 50%
• Uveitis 50%
• Th1 Cell 50%